At a glance
During this COCA Call, subject matter experts from the Centers for Disease Control and Prevention (CDC) will discuss signs and symptoms of Ebola, disease progression, importance of alternative diagnoses or treatments, and the utility of a CDC clinical consult.
Overview
On September 20, 2022, the Ministry of Health of Uganda officially declared an outbreak of Ebola disease caused by Sudan ebolavirus (SUDV). This is the fifth outbreak caused by SUDV in Uganda since 2000. No probable or confirmed cases related to this outbreak have yet been reported in the United States.
During this COCA Call, subject matter experts from the Centers for Disease Control and Prevention (CDC) will discuss signs and symptoms of Ebola, disease progression, importance of alternative diagnoses or treatments, and the utility of a CDC clinical consult. Presenters will also review specimen handling and testing biosafety, and infection prevention and control recommendations.
Presenters
Mary Choi, MD, MPH
CDR, U.S. Public Health Service
Medical Officer, Viral Special Pathogens Branch
Division of High-Consequence Pathogens and Pathology
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Trevor Shoemaker, PhD, MPH
Epidemiologist
Division of High-Consequence Pathogens and Pathology
National Center for Emerging and Zoonotic Diseases
Centers for Disease Control and Prevention
Amy Valderrama, PhD, RN, FAAN
CAPT, U.S. Public Health Service
Nurse Epidemiologist
Division of Healthcare Quality Promotion
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Brian Harcourt, PhD
CDR, U.S. Public Health Service
Biosafety Officer, Viral Special Pathogens Branch
Division of High-Consequence Pathogens and Pathology
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Call Objectives
At the conclusion of the session, the participant will be able to accomplish the following:
- Cite background information on the topic covered during the presentation.
- Discuss CDC's role in the topic covered during the presentation.
- Describe the topic's implications for clinicians.
- Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
- Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of healthcare providers.
Additional Resources
- Ebola virus disease Information for Clinicians in U.S. Healthcare Settings | For Clinicians | Ebola (Ebola Virus Disease) | Ebola Hemorrhagic Fever | CDC
- Screening Patients | For Clinicians | Ebola Virus Disease | CDC
- Viral Hemorrhagic Fevers (VHFs) for Health Care Providers | Viral Hemorrhagic Fevers (VHFs) | CDC
- Ebola Disease Basics | Ebola | CDC
- Signs and Symptoms of Ebola Disease | Ebola | CDC
- How Ebola Disease Spreads | Ebola | CDC
- Infection Prevention and Control Recommendations for Patients in U.S. Hospitals who are Suspected or Confirmed to have Selected Viral Hemorrhagic Fevers (VHF) | Viral Hemorrhagic Fevers (VHFs) | CDC
- VHF Clinical Specimen Packaging and Shipping | Viral Hemorrhagic Fevers (VHFs) | CDC
- Interim Guidance for Preparing Frontline Healthcare Facilities for Patients Suspected to Have Ebola Virus Disease (EVD) | Ebola | CDC
Target Audience
- Physicians
- Nurses
- Pharmacists
- Veterinarians
- Physician Assistants
- Health Educators
- Other Clinicians
Additional Information
- Contact Information: coca@cdc.gov
- Support/Funding: Centers for Disease Control and Prevention, Emergency Risk Communication Branch
- Method of Participation: You may participate in the educational activity by viewing the program information above.